Blood Irradiation Market

The Blood Irradiation Market is anticipated to grow at a CAGR of 5.8% with USD 77.3 Mn in 2026 and is expected to reach USD 113.4 Mn in 2033. The Blood Irradiation Market covers technologies that irradiate blood and blood components to prevent transfusion-associated graft-versus-host disease (TA-GVHD). Irradiation inactivates donor lymphocytes while maintaining the therapeutic quality of red blood cells and other blood components. Hospitals, blood banks, and transfusion centers use irradiation systems to enhance transfusion safety for immunocompromised patients, transplant recipients, and patients undergoing treatments that require irradiated blood products. Healthcare providers increasingly prioritize transfusion safety, infection prevention, and standardized blood-component processing, strengthening demand for blood irradiation technologies. Facilities use X-ray and gamma irradiation systems to treat blood products before transfusion, while technological advances enhance dose accuracy, workflow efficiency, traceability, and operational safety. Hospitals and blood centers are also adopting automated irradiation systems as healthcare infrastructure expands and awareness of transfusion-related complications increases. Market Dynamics Healthcare providers increasingly prioritize blood safety because immunocompromised patients, transplant recipients, and oncology patients require specialized transfusion protocols. Blood irradiation prevents transfusion-associated graft-versus-host disease by inactivating viable donor lymphocytes. Hospitals and blood banks adopt irradiation systems to strengthen patient protection and follow established transfusion practices. Growing clinical awareness, expanding transfusion services, and increasing demand for safer blood-component processing continue to encourage hospitals, blood centers, and specialized treatment facilities to implement irradiation technologies. Manufacturers continue to advance blood irradiation systems by improving dose accuracy, processing consistency, workflow efficiency, and operational safety. X-ray irradiation systems are gaining traction because they deliver controlled irradiation without radioactive sources, simplifying installation and regulatory management in many healthcare settings. Automated controls, digital monitoring, barcode tracking, and integrated documentation further enhance traceability and quality assurance. These technological improvements encourage healthcare facilities to upgrade legacy equipment and adopt more efficient blood-processing solutions. High equipment costs continue to limit adoption, particularly among smaller hospitals and blood banks with restricted capital budgets. Healthcare facilities must also manage radiation-safety procedures, quality controls, maintenance, and staff training when operating irradiation systems. Differences in regulatory requirements across countries can complicate equipment procurement and deployment. Facilities also incur recurring costs for calibration, servicing, validation, and compliance, prompting some institutions to rely on centralized blood irradiation services rather than investing in dedicated equipment. Key Features of the Study • This report provides an in-depth analysis of the Blood Irradiation Market and presents market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year. • It highlights potential revenue opportunities across various market segments and provides attractive investment proposition matrices for stakeholders involved in the Blood Irradiation Market. • This study offers key insights into market drivers, restraints, opportunities, technological advancements, irradiation technologies, transfusion safety requirements, product innovations, regulatory developments, regional outlook, and competitive strategies adopted by leading market participants. • It profiles key players in the Blood Irradiation Market based on company overview, product portfolio, recent developments, technological advancements, financial performance, and strategic initiatives. • Key companies covered as part of this study include Typenex Medical, UVLrx Therapeutics, Best Theratronics, Hitachi Medical Systems, Actemium NDT-PES, Rad Source Technologies, and Gilardoni S.p.A. • Insights from this report enable hospitals, blood banks, transfusion centers, healthcare executives, investors, technology providers, and management teams to make informed decisions regarding equipment procurement, irradiation technology adoption, facility expansion, product development, technology investments, and strategic collaborations. • The Blood Irradiation Market report serves a wide range of stakeholders, including investors, medical equipment manufacturers, blood banks, hospitals, transfusion centers, irradiation technology providers, healthcare distributors, research organizations, new market entrants, and financial analysts. • Stakeholders can make well-informed strategic decisions through the analytical frameworks, competitive benchmarking, technology assessment, regulatory analysis, and market evaluation matrices presented in the Blood Irradiation Market report. Market Segmentation • By Technique (Revenue, USD Mn, 2021-2033) o Intravenous Laser Blood Irradiation o Transcutaneous Laser Blood Irradiation o Extracorporeal Blood Irradiation • By End User (Revenue, USD Mn, 2021-2033) o Hospitals o Blood Bank o Diagnostic Clinics o Research Institutes • By Region (Revenue, USD Mn, 2021-2033) o North America  U.S.  Canada o Latin America  Brazil  Mexico  Argentina  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Spain  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  South Africa  Central Africa  North Africa • Key Players o Typenex Medical o UVLrx Therapeutics o Best Theratronics o Hitachi Medical Systems o Actemium NDT-PES o Rad Source Technologies o Gilardoni S.p.A.